XPO heads into its July 30 earnings report with short sellers unwinding and options traders adding defensive cover — a split setup that makes the positioning read less obvious than it looks.
The short story is one of consistent retreat. Short interest has fallen 8% across the week to 5.2% of the free float, and is down 13% from a month ago. The direction is clear: bears have been reducing exposure steadily since mid-June, when short interest briefly touched above 7.6 million shares. With nearly 86 million shares available to borrow and availability running at 1,221% — well into loose territory — there is no friction in the lending market for anyone who wanted to press a short position. Borrowing costs confirm the same: at 0.49%, cost to borrow is near its lowest point of the past 30 days, down 11% on the week. The borrow market is relaxed. Shorts are leaving not because they are being squeezed out, but because they are choosing to go.
Options positioning tells a different story. The put/call ratio has jumped to 2.34, meaningfully above its 20-day average of 1.97 and roughly one standard deviation elevated. That level has been sustained for over a week — the PCR first broke above 2.30 on July 6 and has not retreated since. With the 52-week PCR range running from 0.65 to 4.02, this week's reading is far from extreme in absolute terms, but the abrupt shift from the 1.5-1.9 range that held through most of June is notable. Options traders are paying more for downside protection than they were a month ago, even as short sellers are walking away.
The analyst community has been unusually active around XPO this week, and the direction is genuinely mixed. UBS lifted its target to $257 and kept its Buy rating. Evercore upgraded the stock to Outperform at the start of the month. Morgan Stanley, maintaining its Underweight, raised its target to $115 — still less than 55% of where XPO trades — a reminder that the bear case here carries real conviction in some quarters, even if the Street's center of gravity has moved higher. Citigroup trimmed its target this week from $226 to $226, while Raymond James cut from $233 to $225 while holding Outperform. Citizens initiated with Market Perform today. The stock at $209.97 sits just below Susquehanna's freshly lifted $214 target. The bull case centres on 15% adjusted EBITDA growth for 2026, driven by pricing and productivity gains in the North American LTL network. Bears flag macro freight exposure and execution risk on the planned European trucking spin-off. One factor score stands out: the analyst recommendation divergence ranks in the 97th percentile universe-wide, meaning the gap between bulls and bears on XPO is wider than almost any other name — unusual for a company with a hold consensus.
Quality metrics provide a supporting backdrop. The Altman Z-score moved from 1.83 to 3.03 over the past six months, crossing above the distress threshold. The Piotroski F-score hit 7, its six-month high. Forward EPS estimates on a year-on-year basis have been revised sharply higher, and the eps_12m_fwd_yoy factor ranks in the 92nd percentile. Institutional ownership reinforces the stability: Capital Research holds 13.9%, BlackRock 10.4%, with several others adding modestly in the June quarter. There is no sign of institutional flight.
Among freight peers, XPO's 3.5% weekly gain broadly matched SAIA at 4.0% and ARCB at 4.4%, while ODFL led the group at 6.1%. The sector recovery this week has been genuine, not a solo XPO move. The July 30 print is the next focal point — prior results produced a 5.1% single-day gain in May and a 0.7% decline in April, leaving the average reaction close to flat, which means the current defensive options positioning will be tested against whatever management reports on freight volume and margin progress.
See the live data behind this article on ORTEX.
Open XPO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
